5 Oct 2026, 14:31
Director Interests—
EVEEVE HEALTH GROUP LIMITED.
Announcement history available from 1 August 2025
Fromto
5 Oct 2026, 14:18
Securities Administration—
22 Sept 2026, 13:43
Meetings & Governance—
22 Sept 2026, 09:10
Presentations—
3 Sept 2026, 18:27
Securities Administration—
31 Aug 2026, 17:22
Company Administration—
31 Aug 2026, 17:22
Financial Results—
31 Aug 2026, 17:18
Financial ResultsMS
7 Aug 2026, 12:43
Quarterly ReportsMS
31 July 2026, 09:47
Quarterly ReportsMS
1 July 2026, 13:35
Director Interests—
1 July 2026, 13:32
Securities Administration—
19 June 2026, 13:51
Securities Administration—
16 June 2026, 08:21
Company UpdateMS
4 June 2026, 12:47
Securities Administration—
22 May 2026, 13:26
Director Interests—
8 May 2026, 16:59
Securities Administration—
8 May 2026, 16:48
Director Interests—
8 May 2026, 16:44
Securities Administration—
8 May 2026, 12:44
Meetings & Governance—
29 Apr 2026, 08:13
Quarterly ReportsMS
28 Apr 2026, 13:03
Substantial Holders—
28 Apr 2026, 08:15
Company AdministrationMS
20 Apr 2026, 18:58
Substantial Holders—
20 Apr 2026, 08:16
Substantial Holders—
8 Apr 2026, 14:25
Substantial Holders—
8 Apr 2026, 08:54
Meetings & Governance—
26 Mar 2026, 08:11
PresentationsMS
25 Mar 2026, 17:22
Substantial Holders—
23 Mar 2026, 09:56
Substantial Holders—
23 Mar 2026, 09:52
Securities Administration—
20 Mar 2026, 11:55
Other—
20 Mar 2026, 11:54
Capital RaisingMS
18 Mar 2026, 18:53
Securities Administration—
18 Mar 2026, 16:16
Capital RaisingMS
13 Mar 2026, 09:39
Securities Administration—
13 Mar 2026, 09:39
Capital RaisingMS
11 Mar 2026, 09:16
Trading Halt / SuspensionMS
10 Mar 2026, 08:22
Company UpdateMS
2 Mar 2026, 08:17
Company Administration—
27 Feb 2026, 16:53
Financial ResultsMS
10 Feb 2026, 09:25
Company UpdateMS
30 Jan 2026, 15:43
Quarterly ReportsMS
30 Jan 2026, 09:04
Company UpdateMS
9 Jan 2026, 08:19
Director Interests—
17 Dec 2025, 13:37
Director Interests—
5 Dec 2025, 15:38
Director Interests—
5 Dec 2025, 15:22
Securities Administration—
5 Dec 2025, 15:19
Securities Administration—
5 Dec 2025, 15:09
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 14:31 | Change of Director's Interest Notice x 3 | Director Interests | — | 02009 | |
| 5 Oct 2026, 14:18 | Notification of cessation of securities - EVE | Securities Administration | — | 06027 | |
| 22 Sept 2026, 13:43 | Date of AGM | Meetings & Governance | — | 08006 | |
| 22 Sept 2026, 09:10 | Coffee Microcaps Conference Presentation | Presentations | — | 03026 | |
| 3 Sept 2026, 18:27 | Release of Securities from Escrow | Securities Administration | — | 06009 | |
| 31 Aug 2026, 17:22 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 31 Aug 2026, 17:22 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 31 Aug 2026, 17:18 | Appendix 4E | Financial Results | MS | 03003 | |
| 7 Aug 2026, 12:43 | Quarterly Activities/Appendix 4C Cash Flow Report - Amended | Quarterly Reports | MS | 19004, 19009 | |
| 31 July 2026, 09:47 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 1 July 2026, 13:35 | Change of Director's Interest Notice x 3 | Director Interests | — | 02009 | |
| 1 July 2026, 13:32 | Notification of cessation of securities - EVE | Securities Administration | — | 06027 | |
| 19 June 2026, 13:51 | Notification of cessation of securities - EVE | Securities Administration | — | 06027 | |
| 16 June 2026, 08:21 | Eve Initiates Pilot Clinical Study for Libbo ED Film | Company Update | MS | 11001 | |
| 4 June 2026, 12:47 | Release of Securities from Escrow | Securities Administration | — | 06009 | |
| 22 May 2026, 13:26 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 8 May 2026, 16:59 | Notification regarding unquoted securities - EVE | Securities Administration | — | 06021 | |
| 8 May 2026, 16:48 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 8 May 2026, 16:44 | Application for quotation of securities - EVE | Securities Administration | — | 06020 | |
| 8 May 2026, 12:44 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 29 Apr 2026, 08:13 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 28 Apr 2026, 13:03 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 28 Apr 2026, 08:15 | Appointment of Chief Executive Officer | Company Administration | MS | 12019 | |
| 20 Apr 2026, 18:58 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 20 Apr 2026, 08:16 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 8 Apr 2026, 14:25 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 8 Apr 2026, 08:54 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 26 Mar 2026, 08:11 | Investor Presentation | Presentations | MS | 03026 | |
| 25 Mar 2026, 17:22 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 23 Mar 2026, 09:56 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 23 Mar 2026, 09:52 | Application for quotation of securities - EVE | Securities Administration | — | 06020 | |
| 20 Mar 2026, 11:55 | Target Market Determination | Other | — | 14001 | |
| 20 Mar 2026, 11:54 | Prospectus | Capital Raising | MS | 06003, 06010 | |
| 18 Mar 2026, 18:53 | Update - Proposed issue of securities - EVE | Securities Administration | — | 06013 | |
| 18 Mar 2026, 16:16 | EVE Placement Update | Capital Raising | MS | 06003 | |
| 13 Mar 2026, 09:39 | Proposed issue of securities - EVE | Securities Administration | — | 06013 | |
| 13 Mar 2026, 09:39 | EVE Raises $0.9m to Advance Drug Reformulation Strategy | Capital Raising | MS | 06003, 09014 | |
| 11 Mar 2026, 09:16 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 10 Mar 2026, 08:22 | EVE Advances Reformulated Drugs Targeting Global Markets | Company Update | MS | 11001 | |
| 2 Mar 2026, 08:17 | Sama Balasubramanian Appointed to Scientific Advisory Board | Company Administration | — | 12008 | |
| 27 Feb 2026, 16:53 | Appendix 4D and Half Year Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 10 Feb 2026, 09:25 | Launch of Libbo and Activation of Men's Health Platform | Company Update | MS | 11001 | |
| 30 Jan 2026, 15:43 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 30 Jan 2026, 09:04 | EVE Completes Initial Production of Libbo | Company Update | MS | 11001 | |
| 9 Jan 2026, 08:19 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 17 Dec 2025, 13:37 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 5 Dec 2025, 15:38 | Change of Director's Interest Notice x 3 | Director Interests | — | 02009 | |
| 5 Dec 2025, 15:22 | Notification regarding unquoted securities - EVE | Securities Administration | — | 06021 | |
| 5 Dec 2025, 15:19 | Notification regarding unquoted securities - EVE | Securities Administration | — | 06021 | |
| 5 Dec 2025, 15:09 | Application for quotation of securities - EVE | Securities Administration | — | 06020 |
1–50 of 80
1 / 2